WallStreetZenWallStreetZen

NASDAQ: ACRV
Acrivon Therapeutics Inc Stock Ownership - Who owns Acrivon Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Acrivon Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Chione Ltd10% Owner2023-06-2616$12.93
$206.88Sell
Rasmus HolmjorgensenChief Financial Officer2023-06-169,500$3.63
$34.49kBuy
Chione Ltd10% Owner2023-06-152,056$12.14
$24.96kSell
Chione Ltd10% Owner2023-06-14893$12.13
$10.83kSell
Chione Ltd10% Owner2023-06-133,000$12.30
$36.90kSell
Chione Ltd10% Owner2023-06-122,000$12.34
$24.68kSell
Eric DevroeChief Operating Officer2023-06-059,225$1.04
$9.59kBuy
Peter BlumejensenPresident and CEO2023-05-3133,605$3.88
$130.39kBuy
Chione Ltd10% Owner2022-11-17400,000$12.50
$5.00MBuy
Ra Capital Management LPDirector2022-11-173,389,500$12.50
$42.37MBuy

1 of 1

ACRV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRV insiders and whales buy or sell their stock.

ACRV Shareholders

What type of owners hold Acrivon Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP21.79%4,810,508$44.98MInstitution
Chione Ltd17.44%3,848,632$35.98MInsider
Kristina Masson16.14%3,562,659$33.31MInsider
Peter Blumejensen15.91%3,512,399$32.84MInsider
Perceptive Advisors LLC13.63%3,007,858$28.12MInsider
Perceptive Advisors LLC13.63%3,007,858$28.12MInstitution
Sands Capital Ventures LLC7.49%1,652,605$15.45MInstitution
Citadel Advisors LLC7.47%1,649,646$15.42MInstitution
Wellington Biomedical Innovation Master Investors Cayman I LP4.02%888,130$8.30MInsider
Wellington Management Group LLP4.02%888,130$8.30MInstitution

1 of 3

ACRV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRV49.62%50.38%Net BuyingNet Selling
ALXO70.08%29.92%Net BuyingNet Selling
GRCL9.45%0.00%
SGMT0.00%44.27%Net BuyingNet Buying
FATE64.94%35.06%Net BuyingNet Selling
View Top Biotech Stocks

Acrivon Therapeutics Stock Ownership FAQ

Who owns Acrivon Therapeutics?

Acrivon Therapeutics (NASDAQ: ACRV) is owned by 68.53% institutional shareholders, 69.58% Acrivon Therapeutics insiders, and 0.00% retail investors. Chione Ltd is the largest individual Acrivon Therapeutics shareholder, owning 3.85M shares representing 17.44% of the company. Chione Ltd's Acrivon Therapeutics shares are currently valued at $35.98M.

If you're new to stock investing, here's how to buy Acrivon Therapeutics stock.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.